drugset / Trial / NCT00533221

Pilot Study of Growth Hormon to Treat SMA Typ II and III

NCT00533221

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Growth hormon can increase strength in spinal muscular atrophy type II and III.

Timeline

Start
2007-10
Primary completion
2010-02
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic 0.03 mg/kg Subcutaneous